Posted inGenetics
End-to-End: Fujifilm Rebrands Life Sciences Companies, Positioning Itself as Drug Development Cycle Leader
Fujifilm Biotechnologies is completing the first phase of a $3.2 billion end-to-end biomanufacturing facility in Holly Springs, NC, set to…